ArticleCureus2025
When Overdose Strikes: Successful Use of Hemodialysis in Valproic Acid Toxicity.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- RENAsym, a quantitative systems toxicology platform model, designed to predict drug-induced kidney injury indicates polymyxin B and valproate overdose toxicity potential while simultaneously demonstrating acetaminophen and valproate safety at therapeutic levels.Toxicological sciences : an official journal of the Society of Toxicology · 2026Article
- Acetylation in renal physiology and pathophysiology.Frontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Valproic acid (VPA) toxicity is a serious and potentially life-threatening condition that can arise from overdose or impaired drug metabolism. While mild cases may present with central nervous system depression, severe toxicity can lead to coma, multi-organ failure, and death. This case report discusses a 21-year-old male with a history of schizoaffective disorder, polysubstance abuse, and suicidal ideations who presented with altered mental status after a suspected overdose of VPA. His serum valproate level was found to be 879 µg/mL, significantly exceeding the therapeutic range. Despite initial supportive care, including intravenous fluids, activated charcoal, and L-carnitine, the patient's condition failed to improve. After consultation with toxicology, neurology, and nephrology teams, the decision was made to initiate continuous renal replacement therapy (CRRT) to expedite the removal of valproate. The patient's mental status gradually improved, and he was successfully extubated after three days of hospitalization. This case highlights the importance of early recognition, aggressive management, and the potential role of hemodialysis in improving outcomes in patients with severe VPA toxicity. Timely intervention can significantly reduce mortality and morbidity associated with VPA overdose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.